Zai Lab Ltd (ZLAB)
29.94
+0.98
(+3.38%)
USD |
NASDAQ |
Nov 13, 16:00
29.50
-0.44
(-1.47%)
After-Hours: 20:00
Zai Lab Debt to Equity Ratio: 0.0998 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0998 |
| March 31, 2024 | 0.0633 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | |
| June 30, 2020 | 0.0091 |
| March 31, 2020 | |
| December 31, 2019 | 0.0219 |
| September 30, 2019 | 0.0189 |
| December 31, 2018 | 0.0145 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
0.0998
Maximum
Jun 2024
0.0114
Average
--
Median
Dec 2020
Debt to Equity Ratio Benchmarks
| Concord Medical Services Holdings Ltd | -1.575 |
| WuXi Biologics (Cayman) Inc | 0.0531 |
| Sinovac Biotech Ltd | 0.0358 |
| CASI Pharmaceuticals Inc | 2.047 |
| Adagene Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 987.37M |
| Total Liabilities (Quarterly) | 283.19M |
| Shareholders Equity (Quarterly) | 704.18M |
| Current Ratio | 3.456 |
| Net Debt Paydown Yield | -0.83% |